Division of Molecular Biosciences, Department of Life Sciences, Imperial College London, London, United Kingdom.
PLoS One. 2012;7(4):e34512. doi: 10.1371/journal.pone.0034512. Epub 2012 Apr 3.
The development of processes to produce biopharmaceuticals industrially is still largely empirical and relies on optimizing both medium formulation and cell line in a product-specific manner. Current small-scale (well plate-based) process development methods cannot provide sufficient sample volume for analysis, to obtain information on nutrient utilization which can be problematic when processes are scaled to industrial fermenters. We envision a platform where essential metabolites can be monitored non-invasively and in real time in an ultra-low volume assay in order to provide additional information on cellular metabolism in high throughput screens. Towards this end, we have developed a model system of Chinese Hamster Ovary cells stably expressing protein-based biosensors for glucose and glutamine. Herein, we demonstrate that these can accurately reflect changing intracellular metabolite concentrations in vivo during batch and fed-batch culture of CHO cells. The ability to monitor intracellular depletion of essential nutrients in high throughput will allow rapid development of improved bioprocesses.
工业化生产生物制药的工艺发展仍然在很大程度上是经验性的,并且依赖于以产品特异性的方式优化培养基配方和细胞系。目前小规模(基于微孔板)的工艺开发方法无法提供足够的分析样品量,无法获得有关营养物质利用的信息,而当工艺放大到工业发酵罐时,这可能会成为一个问题。我们设想了一个平台,可以在超低体积的测定中非侵入性地实时监测必需代谢物,以便在高通量筛选中提供有关细胞代谢的额外信息。为此,我们开发了一种稳定表达基于蛋白质的葡萄糖和谷氨酰胺生物传感器的中国仓鼠卵巢细胞模型系统。在此,我们证明这些生物传感器可以在 CHO 细胞的批式和补料分批培养过程中准确反映体内细胞内代谢物浓度的变化。在高通量水平监测必需营养素的细胞内耗竭的能力将允许快速开发改进的生物工艺。